Dr. Sunil A. Reddy
Claim this profileStanford Cancer Institute Palo Alto
Area of expertise
Melanoma
Sunil A. Reddy has run 6 trials for Melanoma. Some of their research focus areas include:
Skin Cancer
Sunil A. Reddy has run 3 trials for Skin Cancer. Some of their research focus areas include:
Affiliated Hospitals
Stanford Cancer Institute Palo Alto
Stanford
Clinical Trials Sunil A. Reddy is currently running
Ultrasound Techniques
for Detecting Immunotherapy Response in Solid Tumors
Primary objective is to assess whether changes in quantitative tumor perfusion parameters after 3 weeks of treatment, as measured by CEUS, can predict initial objective response to therapy, defined by current standard-of-care Secondary objectives are to evaluate if there is an optimal ultrasound imaging modality (CEUS or conventional power Doppler or LEAD ultrasound) or optimal time point to predict initial objective response and to assess the correlation of tumor perfusion parameters with change in overall tumor burden, change in diameter on a per-lesion basis, and with 12-month progression-free survival (PFS).
Recruiting
1 award
N/A
Nivolumab + Cabozantinib
for Melanoma
This trial tests if nivolumab and cabozantinib can help patients with mucosal melanoma. Nivolumab boosts the immune system, while cabozantinib stops cancer cells from growing. The goal is to prevent the cancer from coming back or spreading. Nivolumab and cabozantinib have shown efficacy in treating various cancers, including melanoma and renal cell carcinoma.
Recruiting
0 awards
Phase 2
More about Sunil A. Reddy
Clinical Trial Related
10 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Sunil A. Reddy has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- Doppler Ultrasound
- Long Ensemble Angular-coherence Doppler [LEAD] Ultrasound
- Contrast-enhanced Ultrasound (CEUS)
Breakdown of trials Sunil A. Reddy has run
Melanoma
Skin Cancer
Eye Cancer
Uveal Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sunil A. Reddy specialize in?
Sunil A. Reddy focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Sunil A. Reddy currently recruiting for clinical trials?
Yes, Sunil A. Reddy is currently recruiting for 2 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Sunil A. Reddy has studied deeply?
Yes, Sunil A. Reddy has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Sunil A. Reddy?
Apply for one of the trials that Sunil A. Reddy is conducting.
What is the office address of Sunil A. Reddy?
The office of Sunil A. Reddy is located at: Stanford Cancer Institute Palo Alto, Palo Alto, California 94304 United States. This is the address for their practice at the Stanford Cancer Institute Palo Alto.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.